INM (STOCKS)
InMed Pharmaceuticals Inc. Common Shares
$1.510000
+0.000000 (+0.00%)
Prev close: $1.510000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Eric A. Adams
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $5.00M
- Employees
- 13
- P/E (TTM)
- -0.59
- P/B (TTM)
- 0.73
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
0
Strong Buy
0
Buy
3
Hold
4
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-1.94 | $0.00 | +0.0000 | +0.00% |
|
Jun 2024 (Q2)
|
$-0.19 | $0.00 | +0.0000 | +0.00% |
|
Mar 2024 (Q1)
|
$-0.76 | $0.00 | +0.0000 | +0.00% |
|
Jun 2022 (Q4)
|
$-280.60 | $-111.10 | -169.5000 | -152.57% |
Financial Statements
| Operating Expenses | $10.39M |
| Depreciation and Amortization | $212.66K |
| Research and Development | $2.84M |
| Other Operating Expenses | $7.34M |
| Income/Loss From Continuing Operations After Tax | -$7.85M |
| Income/Loss From Continuing Operations Before Tax | -$7.85M |
| Net Income/Loss | -$8.51M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$8.51M |
| Net Income/Loss Available To Common Stockholders, Basic | -$8.51M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$2.11 |
| Diluted Earnings Per Share | -$2.11 |
| Basic Average Shares | 8,174,834 |
| Diluted Average Shares | 8,174,834 |
| Assets | $9.13M |
| Current Assets | $6.89M |
| Cash | $5.20M |
| Other Current Assets | $1.69M |
| Noncurrent Assets | $2.25M |
| Fixed Assets | $642.88K |
| Intangible Assets | $1.50M |
| Other Non-current Assets | $104.37K |
| Liabilities | $2.24M |
| Current Liabilities | $2.21M |
| Wages | $373.54K |
| Other Current Liabilities | $1.84M |
| Noncurrent Liabilities | $30.77K |
| Equity | $6.89M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $6.89M |
| Liabilities And Equity | $9.13M |
| Net Cash Flow From Operating Activities | -$7.46M |
| Net Cash Flow From Operating Activities, Continuing | -$8.21M |
| Net Cash Flow From Investing Activities | -$811.55K |
| Net Cash Flow From Investing Activities, Continuing | -$54.53K |
| Net Cash Flow From Financing Activities | $8.27M |
| Net Cash Flow From Financing Activities, Continuing | $8.27M |
| Net Cash Flow | $0.00 |
| Net Cash Flow, Continuing | $0.00 |
| Comprehensive Income/Loss | -$8.51M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$8.51M |
| Other Comprehensive Income/Loss | $0.00 |